Gene · 1445
Papers4,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Syncope in the setting of trifascicular block and retrograde concealed conduction: A case report. | Med Int (Lond) | 2023 | 38099149 | PubTator, text mining | PubMed |
| Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy. | Cell Rep Med | 2023 | 38091986 | PubTator, text mining | PubMed |
| The expanding Pandora's toolbox of CD8+T cell: from transcriptional control to metabolic firing. | J Transl Med | 2023 | 38082437 | PubTator, text mining | PubMed |
| The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds. | Int J Mol Sci | 2023 | 38069175 | PubTator, text mining | PubMed |
| Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration. | Cells | 2023 | 38067097 | PubTator, text mining | PubMed |
| MMP-2 regulates Src activation via repression of the CHK/MATK tumor suppressor in osteosarcoma. | Cancer Rep (Hoboken) | 2023 | 38064181 | PubTator, text mining | PubMed |
| Protocol to characterize extracellular c-Src tyrosine kinase function through substrate interaction and phosphorylation. | STAR Protoc | 2023 | 38043058 | PubTator, text mining | PubMed |
| CurveCurator: a recalibrated F-statistic to assess, classify, and explore significance of dose-response curves. | Nat Commun | 2023 | 38036588 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis and fine-mapping prioritize potential causal variants and genes related to leprosy. | MedComm (2020) | 2023 | 38020709 | PubTator, text mining | PubMed |
| Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma. | Biomolecules | 2023 | 38002311 | PubTator, text mining | PubMed |
| Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches. | Cancers (Basel) | 2023 | 38001644 | PubTator, text mining | PubMed |
| Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC. | Sci Rep | 2023 | 37989860 | PubTator, text mining | PubMed |
| Genome-Wide Interaction Analysis with DASH Diet Score Identified Novel Loci for Systolic Blood Pressure. | medRxiv | 2023 | 37986948 | PubTator, text mining | PubMed |
| LAIR-1 agonism as a therapy for acute myeloid leukemia. | J Clin Invest | 2023 | 37966113 | PubTator, text mining | PubMed |
| Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy. | Proc Natl Acad Sci U S A | 2023 | 37963244 | PubTator, text mining | PubMed |
| Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses. | Sci Rep | 2023 | 37949863 | PubTator, text mining | PubMed |
| Pericentrin deficiency in smooth muscle cells augments atherosclerosis through HSF1-driven cholesterol biosynthesis and PERK activation. | JCI Insight | 2023 | 37937642 | PubTator, text mining | PubMed |
| Harnessing CD3 diversity to optimize CAR T cells. | Nat Immunol | 2023 | 37932456 | PubTator, text mining | PubMed |
| TCR Pathway Mutations in Mature T Cell Lymphomas. | J Immunol | 2023 | 37931208 | PubTator, text mining | PubMed |
| Astragalin: a food-origin flavonoid with therapeutic effect for multiple diseases. | Front Pharmacol | 2023 | 37920216 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1445/papers?page=8